Sukhtian Faisal Ghiath bought OTLK

July 29, 2026 · Form 4 insider transaction

Sukhtian Faisal Ghiath bought 95,398 shares of Outlook Therapeutics, Inc. at $1.05 per share, a transaction worth $100.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.